Centre Antoine - Lacassagne - Developmental Therapeutics Review - Q4 2010

Global Markets Direct, December 2010, Pages: 29

Centre Antoine - Lacassagne – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Centre Antoine - Lacassagne – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Centre Antoine - Lacassagne.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Centre Antoine - Lacassagne with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Centre Antoine - Lacassagne’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Review of therapeutics under development by Centre Antoine - Lacassagne.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Centre Antoine - Lacassagne with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Centre Antoine - Lacassagne’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

List of Tables
List of Figures
Centre Antoine - Lacassagne Snapshot
Key Facts
Centre Antoine - Lacassagne – Research and Development Overview
Key Therapeutic Areas
Centre Antoine - Lacassagne – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Centre Antoine - Lacassagne – Pipeline Products Glance
Centre Antoine - Lacassagne Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Centre Antoine - Lacassagne – Drug Profiles
Cetuximab + Cisplatin + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
doxorubicin + vincristine + cyclophosphamide + prednisone + rituximab + yttrium Y 90 ibritumomab
Product Description
Mechanism of Action
R&D Progress
Cyclophosphamide + Docetaxel + Epirubicin hydrochloride + Fluorouracil + Radiation therapy
Product Description
Mechanism of Action
R&D Progress
Gemcitabine + Capecitabine + Erlotinib
Product Description
Mechanism of Action
R&D Progress
Centre Antoine - Lacassagne – Pipeline Analysis
Centre Antoine - Lacassagne – Pipeline Products by Therapeutic Class
Centre Antoine - Lacassagne Pipeline Products By Target
Centre Antoine - Lacassagne – Pipeline Products by Route of Administration
Centre Antoine - Lacassagne – Pipeline Products by Molecule Type
Centre Antoine - Lacassagne – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles
• eLEARNING - Global Strategic Business Report
• Charter Schools - Global Outlook
• Aerospace and Defense Industry - Global Strategic Business Report
• Unmanned Maritime Systems - Defense & Security UUV & USV – Markets, Technologies & Opportunities Outlook – 2012-2020
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Directory of the United Nations 2013
• International Military and Civilian Unmanned Aerial Vehicle Survey
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• Generic Defense Strategies: Lifecycle Management Strategies to Maximize Revenue in the Face of Growing Generic Competition